Clinical significance and molecular characteristics of circulating tumor cells and circulating tumor microemboli in patients with small-cell lung cancer.
By Jian-mei Hou, M. Krebs, L. Lancashire, R. Sloane, A. Backen, R. Swain, L. Priest, A. Greystoke, Cong Zhou, K. Morris and 3 more. Journal of Clinical Oncology, 2012
772 citations recorded by the source corpus.
Subfields: Cancer Research, Oncology
View Paper: https://www.semanticscholar.org/paper/ea54dd19f7308032061c3b74725364b6ed61b8d5
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Oncology
Citations in the corpus
- Liquid Biopsy: From Discovery to Clinical Application. (2021, background): “Encouraging results were also achieved for other tumor entities, including lung cancer (7, 8), bladder cancer (78, 79), head and neck cancer (40, 80, 81), testicular germ cell tumors (82), colorectal cancer (including stage II; refs.”
- Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters (2016, background): “Tumor cell clusters are detected in the bloodstream of cancer patients (2), clusters can efficiently seed metastases (3), and though rare, circulating tumor cell (CTC) clusters have prognostic significance (4, 5).”
- Implications of the Hybrid Epithelial/Mesenchymal Phenotype in Metastasis (2015, background): “se clusters, also referred to as microemboli¶, can be apoptosis-resistant, are more likely to be trapped in narrow blood vessels for extravasation, and often correlate with poor prognosis in patients (11,14,15,114). Although these clusters constitute only 3% of total CTC µevents¶ observed (97% being”